| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-72601 |
GSK3640254
|
1818867-24-1 |
GSK3640254 (GSK254, Fipravirimat) is a novel potent HIV-1 maturation inhibitor with EC90 of 33 nM against a minilibrary of clinically relevant HIV-1 polymorphisms in a multiple-cycle assay. |
| PC-36055 |
ABX464
|
1258453-75-6 |
Obefazimod (ABX464) is a novel class of anti-HIV small molecule targeting Rev-mediated viral RNA biogenesis, shows dose dependent inhibition of HIV-1 replication in stimulated PBMCs with IC50 of 0.1-0.5 uM. |
| PC-35751 |
NSC260594
|
906718-66-9 |
NSC260594 (NSC 260594) is a specific inhibitor of HIV-1 RNA packaging, which involves preventing the interaction of Gag with SL3 by stabilizing this small RNA stem-loop which then leads to stabilization of the global packaging signal region (psi or ψ). |
| PC-35225 |
NBD-14189
|
2234273-72-2 |
NBD-14189 (NBD14189) is a novel potent HIV-1 entry antagonist with potency as low as 63 nM against some clinical isolates, target HIV-1 gp120.. |
| PC-43512 |
TAK-779
|
229005-80-5 |
TAK-779 is a potent, specific, nonpeptide CCR5 antagonist with Kd of 0.45 nM, antagonizes CCR2b to a lesser extent (27 nM) but does not affect CCR1, CCR3, or CCR4. |
| PC-43448 |
BMS-707035
|
729607-74-3 |
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.. |
| PC-43417 |
Dolutegravir
|
1051375-16-6 |
Dolutegravir (GSK1349572) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM. |
